Journal of Pharmaceutical Analysis
Scope & Guideline
Bridging the gap between research and application in pharmaceuticals.
Introduction
Aims and Scopes
- Pharmaceutical Chemistry and Drug Development:
Research in this area focuses on the chemical properties and synthesis of pharmaceutical compounds, exploring novel drug formulations and their therapeutic efficacy. - Analytical Method Development:
The journal emphasizes the development and validation of analytical methods using various techniques such as mass spectrometry, chromatography, and spectroscopy for the quantification and characterization of drugs and their metabolites. - Natural Products and Traditional Medicine:
There is a significant focus on the analysis of natural compounds, including those derived from traditional Chinese medicine, and their pharmacological effects, contributing to the understanding of herbal medicine in modern therapeutics. - Pharmacokinetics and Drug Metabolism:
Studies that investigate the absorption, distribution, metabolism, and excretion (ADME) of drugs, providing insights into their pharmacokinetic profiles and potential therapeutic implications. - Toxicology and Drug Safety:
Research dedicated to understanding the safety profiles of drugs and their metabolites, including studies on toxicological implications and risk assessments. - Nanomedicine and Drug Delivery Systems:
Innovative approaches to drug delivery using nanotechnology, focusing on enhancing the efficacy and bioavailability of therapeutic agents through novel delivery systems. - Omics Technologies:
The integration of multi-omics approaches such as genomics, proteomics, and metabolomics to elucidate complex biological interactions and inform drug development processes. - Machine Learning and Data Analysis:
The application of machine learning techniques in analyzing complex pharmaceutical data, enhancing predictive modeling and decision-making in drug development.
Trending and Emerging
- Sustainable and Green Analytical Chemistry:
Research is increasingly focused on developing eco-friendly analytical methods, such as green chemistry practices in pharmaceutical analysis, reflecting a broader societal shift towards sustainability. - Advanced Mass Spectrometry Techniques:
There is a notable trend towards the utilization of advanced mass spectrometry techniques, including high-resolution and imaging mass spectrometry, to enhance the sensitivity and specificity of drug analysis. - Integration of Artificial Intelligence and Machine Learning:
The application of AI and machine learning in drug discovery and analysis is rapidly gaining traction, enabling more efficient data processing and predictive modeling for pharmaceutical research. - Personalized Medicine and Pharmacogenomics:
Emerging research is increasingly focused on personalized medicine approaches, utilizing pharmacogenomics to tailor drug therapies based on individual genetic profiles. - Targeted Drug Delivery Systems:
There is a growing emphasis on the development of targeted drug delivery systems, including nanoparticles and other novel carriers, to enhance therapeutic outcomes and reduce side effects. - Microbiome and Drug Interaction Studies:
Investigations into the interactions between the gut microbiome and pharmaceutical compounds are on the rise, highlighting the importance of microbiome research in understanding drug metabolism and efficacy. - High-Throughput Screening Techniques:
The trend towards high-throughput screening methodologies for drug discovery and analysis is expanding, allowing for rapid evaluation of large compound libraries. - Immunotherapy and Biologics Analysis:
Research focusing on the analytical challenges and methodologies associated with biologics and immunotherapeutic agents is increasingly prominent, reflecting the growing importance of these therapies in modern medicine.
Declining or Waning
- Conventional Drug Formulations:
There appears to be a diminishing emphasis on traditional drug formulation studies, as researchers increasingly explore more innovative and complex drug delivery systems. - Basic Pharmacology Studies:
Research focusing purely on basic pharmacological studies without the integration of advanced analytical techniques is becoming less prevalent, as the field moves towards more data-driven and technology-enhanced approaches. - In vitro Toxicity Testing:
The frequency of studies solely centered around in vitro toxicity testing is decreasing, with a shift towards more comprehensive in vivo studies and the use of computational models. - Single-Sample Analytical Techniques:
Research employing single-sample analytical methodologies without the incorporation of multiplexing or high-throughput screening techniques is seeing reduced interest, as the demand for efficiency and comprehensive data increases. - Historical Drug Analysis:
There is a waning interest in the analysis of historical drug formulations and their methodologies, as the focus shifts towards contemporary and future-oriented pharmaceutical innovations.
Similar Journals
BMC Chemistry
Elevating Chemical Science with Impactful ResearchBMC Chemistry, published by BMC, is a reputable open access journal that has made significant strides since its inception in 2019. Operating under e-ISSN 2661-801X, this journal is dedicated to advancing the field of general chemistry by promoting high-quality research across various sub-disciplines. Headquartered in the United Kingdom, BMC Chemistry boasts a commendable impact factor and is classified in Q2 within the prestigious field of Chemistry (miscellaneous) according to the 2023 category quartiles. The journal's Scopus ranking places it at #139 out of 408 in its category, highlighting its growing relevance and influence in the academic community, with a commendable 66th percentile standing. With a commitment to open access, BMC Chemistry ensures that groundbreaking discoveries and innovative research are available to a global audience, fostering collaboration and development in chemistry. Researchers, professionals, and students alike will find this journal to be an invaluable resource for disseminating knowledge and driving scientific advancement.
Turkish Journal of Pharmaceutical Sciences
Shaping the Future of Healthcare Through ResearchThe Turkish Journal of Pharmaceutical Sciences, an esteemed publication by GALENOS PUBL HOUSE, has been a prominent platform for research and innovation in the fields of Pharmaceutical Sciences and Molecular Medicine since its inception as an Open Access journal in 2004. Based in Turkey, this journal serves as a vital resource for researchers, professionals, and students keen on exploring the latest advancements in drug development, pharmacology, and therapeutic innovations. With an ISSN of 1304-530X and an E-ISSN of 2148-6247, the journal is indexed in leading databases and has demonstrated strong rankings in the Scopus index, notably securing the second quartile in Pharmaceutical Sciences. Furthermore, it fosters academic collaboration and knowledge dissemination by making its content freely accessible. The journal aims to inspire groundbreaking research, providing an important academic forum for the dissemination of valuable insights that impact the pharmaceutical sector and contribute to global health.
Istanbul Journal of Pharmacy
Empowering research, enhancing pharmacy practice.Istanbul Journal of Pharmacy, published by Istanbul University, Faculty of Pharmacy, is a pivotal platform dedicated to the advancement of pharmaceutical sciences and technology. This journal serves as a vital resource for researchers, professionals, and students alike, seeking to disseminate cutting-edge research, reviews, and innovative methodologies within the pharmaceutical discipline. With a commitment to open access, the journal aims to foster a collaborative environment that promotes information sharing and scholarly discourse. The Istanbul Journal of Pharmacy invites submissions that delve into diverse topics ranging from drug formulation to pharmacokinetics, ensuring that readers are equipped with the latest insights and discoveries in the field. This journal is positioned to enhance scientific communication within the pharmaceutical community and support the continuous evolution of pharmacy practice and education globally.
European Journal of Pharmacology
Unveiling groundbreaking research in pharmacokinetics and toxicology.The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.
BIOLOGICAL & PHARMACEUTICAL BULLETIN
Unlocking New Horizons in Pharmaceutical ResearchBIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH
Empowering researchers to shape the future of pharmaceutical sciences.Tropical Journal of Pharmaceutical Research is an esteemed open-access platform dedicated to advancing the field of pharmaceutical sciences, published by the Pharmacotherapy Group in Nigeria. With an ISSN of 1596-5996 and open access established since 2002, this journal serves as a critical resource for researchers, professionals, and students seeking to disseminate and access high-quality research in both pharmaceutical science and pharmacology. Despite its ranking in the third quartile (Q3) for Pharmaceutical Science and the fourth quartile (Q4) in Pharmacology as of 2023, the journal continues to stand out with its commitment to fostering significant dialogue and innovation in the scientific community. Anchored at the University of Benin, Faculty of Pharmacy, the journal invites contributions that explore novel pharmaceutical research, clinical applications, and drug development, playing a vital role in addressing health challenges that are particularly relevant to tropical regions. Researchers can look forward to publishing their findings in a journal that not only promotes the sharing of knowledge but also enhances the scientific discourse within a rapidly evolving field.
Iranian Journal of Pharmaceutical Research
Advancing pharmaceutical knowledge for a healthier tomorrow.Welcome to the Iranian Journal of Pharmaceutical Research, a pioneering publication in the field of pharmacology, toxicology, and pharmaceutics, published by BRIEFLAND. Established in 2002, this journal has been a crucial platform for disseminating innovative research and scholarly articles, contributing significantly to the advancement of pharmaceutical sciences in Iran and beyond. With an impressive trajectory leading towards a convergence of knowledge by 2024, it proudly holds a Q3 ranking in Pharmacology (Medical) and a Q2 ranking in the broader realm of Pharmacology, Toxicology, and Pharmaceutics for 2023. The journal's influence is underscored by its Scopus rank of #25/80 in General Pharmacology, Toxicology, and Pharmaceutics, placing it within the 69th percentile, therefore appealing to researchers, professionals, and students alike. Although the journal operates under a non-open access model, it remains dedicated to providing high-quality research articles that explore the latest advancements in pharmaceutical sciences, making it an essential resource for anyone involved in this vibrant field of study.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY
Exploring the Frontiers of Drug DevelopmentDrug Development and Industrial Pharmacy is a prestigious journal published by Taylor & Francis Ltd, focusing on the critical field of pharmaceutical sciences. With an ISSN of 0363-9045 and an E-ISSN of 1520-5762, the journal has been an essential resource for researchers and professionals since its inception in 1974. It occupies a crucial niche within Drug Discovery, Organic Chemistry, and Pharmaceutical Science, currently ranked in the second and third quartiles, reflecting its solid contribution to the field. The journal encompasses a wide array of topics, including drug development processes, formulation, and industrial manufacturing alongside cutting-edge research in pharmacology and toxicology. With a commendable Scopus ranking demonstrating high relevance—ranked #44 in Pharmaceutical Science—it serves as a vital forum for academia and industry to share innovative findings and methodologies. While it does not offer open access, the journal remains an invaluable resource for those seeking to advance their knowledge and enhance their research in pharmaceutical development.
ACTA PHARMACEUTICA
Connecting scholars and practitioners with cutting-edge insights.ACTA PHARMACEUTICA is a distinguished open-access journal published by SCIENDO, dedicated to advancing knowledge in the fields of medicine and pharmaceutical sciences. Established in 1992, the journal has made significant contributions to the scholarly community, providing a platform for innovative research and discussion. With a strong presence in both Q2 and Q3 quartiles across various categories including Pharmaceutical Science and Pharmacology, ACTA PHARMACEUTICA ranks favorably, positioning its contributions in the upper tiers of the field. The journal's commitment to open access since 2007 ensures that both practitioners and scholars have immediate access to cutting-edge developments, thereby fostering collaboration and knowledge sharing. With its scope spanning a broad spectrum of pharmaceutical and biomedical research, ACTA PHARMACEUTICA is an essential resource for researchers, professionals, and students keen to stay abreast of the latest advancements and trends in these vital areas of study.
Frontiers in Pharmacology
Driving excellence in pharmacological research and education.Frontiers in Pharmacology, published by FRONTIERS MEDIA SA, stands as a leading open-access journal dedicated to advancing the field of pharmacology since its inception in 2010. With its ISSN 1663-9812, the journal is based in Switzerland and maintains a vital role in disseminating innovative research findings that span various disciplines within pharmacology, including pharmacokinetics, toxicology, and pharmacogenetics. In 2023, Frontiers in Pharmacology has achieved an impressive standing within the scientific community, being ranked in the Q1 category for both general and medical pharmacology, highlighting its critical contribution to the field with a Scopus ranking of #41 out of 272 in medical pharmacology and #76 out of 313 in pharmacology, toxicology, and pharmaceutics, placing it in the 75th and 85th percentiles, respectively. Researchers and practitioners benefit from its open-access model, which ensures widespread accessibility to groundbreaking research, fostering collaboration and innovation across the pharmaceutical sciences. With its commitment to excellence, Frontiers in Pharmacology serves as an essential resource for those looking to explore and contribute to the latest advancements in pharmacological research.